myirislogo
21 October, 2019 07:49 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
Tata Motors 136.70 1.05
State Bank O 269.65 1.58
Tata Stl 359.90 1.19
Tata Power 60.05 0.42
Reliance 1415.30 1.37
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Morepen Laboratories Limited
Morepen Laboratories Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
BSE:500288NSE:MOREPENLABBloomberg:MORE@INReuters:MORL.BO
Market Lot: 1Face Value: 2ISIN Demat: INE083A01026
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
30-JUL-18 Morepen Laboratories has received US FDA (United States Food and Drug Administration) approvals for both its bulk drugs manufacturing facilities situated in Himachal Pradesh. While the Baddi facility has got US FDA approval for the manufacture of bulk drug 21-DEC-17 Morepen Laboratories has received approval from United States Food and Drug Administration (USFDA) for Montelukast Sodium, a bulk drug/ API to sell in the US market. 11...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Morepen Lab gets USFDA clearance for bulk drug Montelukast Sodium  -IRIS 21-Dec-17
Previous

 


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Dec-2018(9)31-Mar-2018 (12)31-Mar-2017 (12)
Net sales 3604.345608.305370.35
Other Income26.4435.4036.95
Total Income3630.785643.705407.30
Cost of goods sold-3461.605048.555176.89
OPBDIT7092.38595.15230.41
PAT194.92261.15230.42
Gross Block---
Equity capital-0.000.00
EPS (Rs.)-0.000.00
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-NANA
Debt / Equity (x)---
Operating margin (% of OI)195.310.5 4.3
Net margin (% of OI) 5.4 4.6 4.3
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Morepen Village
Nalagarh Road
Near Baddi
Solan
Himachal Pradesh-173 205
PHONE
(01795) 2464 01/ 02/ 03/ 2445 90
FAX
(01795) 2445 91
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer